Singapore: Guinea government officials have announced that the anti-ebola experimental drug, being developed by Toyama Chemical, a subsidary of Fujifilm, has been approved. The drug, which showed positive results in inital trials, will now be available at all Ebola treatment units.

This decision comes after the deadly disease reversed its decline and more new cases came to light. The trials for the drug have been on since mid-december by both French and Guinean teams in Southern Guineam although no details of the trials themselves have been released.

Nearby villages in the three worst effected regions of West Africa, namely, Sierra Leone, Guniea and Liberia previosuly thought resistant are also being closely monitored, said government officials.